ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 34 filers reported holding ELEDON PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,874 | +3.5% | 1,217,882 | 0.0% | 0.19% | +1.6% |
| Q4 2022 | $2,777 | -99.9% | 1,217,882 | -0.5% | 0.19% | -21.2% |
| Q3 2022 | $3,377,000 | +6.1% | 1,223,500 | -6.3% | 0.24% | -2.1% |
| Q2 2022 | $3,184,000 | -38.1% | 1,305,095 | 0.0% | 0.24% | -39.0% |
| Q1 2022 | $5,142,000 | -10.7% | 1,305,095 | 0.0% | 0.40% | +15.5% |
| Q4 2021 | $5,755,000 | -28.6% | 1,305,095 | 0.0% | 0.34% | +4.3% |
| Q3 2021 | $8,065,000 | -28.0% | 1,305,095 | -7.8% | 0.33% | -13.7% |
| Q2 2021 | $11,197,000 | -26.1% | 1,415,500 | 0.0% | 0.38% | +12.8% |
| Q1 2021 | $15,146,000 | – | 1,415,500 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 245,000 | $676,000 | 0.76% |
| BVF INC/IL | 2,326,710 | $6,422,000 | 0.26% |
| Cormorant Asset Management, LP | 1,223,500 | $3,377,000 | 0.24% |
| Ikarian Capital, LLC | 221,830 | $612,000 | 0.12% |
| JMAC ENTERPRISES LLC | 54,538 | $151,000 | 0.04% |
| Woodline Partners LP | 516,675 | $1,426,000 | 0.02% |
| Eversept Partners, LP | 67,743 | $186,971 | 0.02% |
| INGALLS & SNYDER LLC | 51,149 | $141,000 | 0.01% |
| Point72 Asset Management, L.P. | 375,000 | $1,035,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 22,050 | $61,000 | 0.00% |